vs
Side-by-side financial comparison of JBT Marel Corp (JBTM) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.0B, roughly 1.5× JBT Marel Corp). JBT Marel Corp runs the higher net margin — 5.3% vs -13.6%, a 18.9% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $83.5M). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs -3.6%).
JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
JBTM vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.5B |
| Net Profit | $53.1M | $-205.0M |
| Gross Margin | 34.5% | 49.2% |
| Operating Margin | 7.2% | -9.8% |
| Net Margin | 5.3% | -13.6% |
| Revenue YoY | 115.6% | -5.3% |
| Net Profit YoY | 858.6% | -288.1% |
| EPS (diluted) | $1.04 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $1.0B | $1.6B | ||
| Q2 25 | $934.8M | $1.6B | ||
| Q1 25 | $854.1M | $1.5B | ||
| Q4 24 | $467.6M | $1.6B | ||
| Q3 24 | $453.8M | $1.6B | ||
| Q2 24 | $402.3M | $1.6B | ||
| Q1 24 | $392.3M | $1.6B |
| Q4 25 | $53.1M | $-205.0M | ||
| Q3 25 | $66.0M | $160.0M | ||
| Q2 25 | $3.4M | $145.0M | ||
| Q1 25 | $-173.0M | $87.0M | ||
| Q4 24 | $-7.0M | $109.0M | ||
| Q3 24 | $38.9M | $359.0M | ||
| Q2 24 | $30.7M | $195.0M | ||
| Q1 24 | $22.8M | $201.0M |
| Q4 25 | 34.5% | 49.2% | ||
| Q3 25 | 35.9% | 53.5% | ||
| Q2 25 | 35.8% | 54.8% | ||
| Q1 25 | 34.2% | 55.6% | ||
| Q4 24 | 38.4% | 56.3% | ||
| Q3 24 | 36.1% | 58.3% | ||
| Q2 24 | 35.6% | 58.4% | ||
| Q1 24 | 35.8% | 59.0% |
| Q4 25 | 7.2% | -9.8% | ||
| Q3 25 | 10.2% | 15.2% | ||
| Q2 25 | 5.2% | 14.4% | ||
| Q1 25 | -3.9% | 6.7% | ||
| Q4 24 | 3.4% | 8.1% | ||
| Q3 24 | 10.3% | 13.1% | ||
| Q2 24 | 6.7% | 14.6% | ||
| Q1 24 | 7.4% | 14.5% |
| Q4 25 | 5.3% | -13.6% | ||
| Q3 25 | 6.6% | 10.0% | ||
| Q2 25 | 0.4% | 9.1% | ||
| Q1 25 | -20.3% | 5.8% | ||
| Q4 24 | -1.5% | 6.8% | ||
| Q3 24 | 8.6% | 22.7% | ||
| Q2 24 | 7.6% | 12.1% | ||
| Q1 24 | 5.8% | 12.4% |
| Q4 25 | $1.04 | $-0.78 | ||
| Q3 25 | $1.26 | $0.61 | ||
| Q2 25 | $0.07 | $0.56 | ||
| Q1 25 | $-3.35 | $0.33 | ||
| Q4 24 | $-0.22 | $0.42 | ||
| Q3 24 | $1.21 | $1.38 | ||
| Q2 24 | $0.95 | $0.75 | ||
| Q1 24 | $0.71 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $574.0M |
| Total DebtLower is stronger | $1.5B | $8.6B |
| Stockholders' EquityBook value | $4.5B | $752.0M |
| Total Assets | $8.2B | $12.9B |
| Debt / EquityLower = less leverage | 0.33× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $574.0M | ||
| Q3 25 | — | $672.0M | ||
| Q2 25 | — | $599.0M | ||
| Q1 25 | — | $547.0M | ||
| Q4 24 | $1.2B | $675.0M | ||
| Q3 24 | — | $763.0M | ||
| Q2 24 | — | $704.0M | ||
| Q1 24 | — | $575.0M |
| Q4 25 | $1.5B | $8.6B | ||
| Q3 25 | $1.5B | $8.8B | ||
| Q2 25 | $1.5B | $8.9B | ||
| Q1 25 | $2.0B | $9.0B | ||
| Q4 24 | $1.3B | $8.9B | ||
| Q3 24 | $648.3M | $8.7B | ||
| Q2 24 | $647.7M | $8.7B | ||
| Q1 24 | $647.0M | $8.7B |
| Q4 25 | $4.5B | $752.0M | ||
| Q3 25 | $4.4B | $906.0M | ||
| Q2 25 | $4.4B | $733.0M | ||
| Q1 25 | $4.1B | $542.0M | ||
| Q4 24 | $1.5B | $472.0M | ||
| Q3 24 | $1.6B | $493.0M | ||
| Q2 24 | $1.5B | $144.0M | ||
| Q1 24 | $1.5B | $48.0M |
| Q4 25 | $8.2B | $12.9B | ||
| Q3 25 | $8.2B | $13.6B | ||
| Q2 25 | $8.3B | $13.5B | ||
| Q1 25 | $8.0B | $13.2B | ||
| Q4 24 | $3.4B | $13.1B | ||
| Q3 24 | $2.8B | $12.8B | ||
| Q2 24 | $2.7B | $12.2B | ||
| Q1 24 | $2.7B | $11.9B |
| Q4 25 | 0.33× | 11.49× | ||
| Q3 25 | 0.34× | 9.74× | ||
| Q2 25 | 0.35× | 12.14× | ||
| Q1 25 | 0.48× | 16.52× | ||
| Q4 24 | 0.81× | 18.81× | ||
| Q3 24 | 0.41× | 17.75× | ||
| Q2 24 | 0.43× | 60.11× | ||
| Q1 24 | 0.43× | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $117.4M | $141.0M |
| Free Cash FlowOCF − Capex | $83.5M | $96.0M |
| FCF MarginFCF / Revenue | 8.3% | 6.4% |
| Capex IntensityCapex / Revenue | 3.4% | 3.0% |
| Cash ConversionOCF / Net Profit | 2.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $238.1M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $117.4M | $141.0M | ||
| Q3 25 | $87.7M | $264.0M | ||
| Q2 25 | $102.2M | $220.0M | ||
| Q1 25 | $34.4M | $75.0M | ||
| Q4 24 | $128.7M | $390.0M | ||
| Q3 24 | $71.9M | $141.0M | ||
| Q2 24 | $21.6M | $332.0M | ||
| Q1 24 | $10.4M | $76.0M |
| Q4 25 | $83.5M | $96.0M | ||
| Q3 25 | $56.5M | $218.0M | ||
| Q2 25 | $83.7M | $181.0M | ||
| Q1 25 | $14.4M | $43.0M | ||
| Q4 24 | $118.7M | $335.0M | ||
| Q3 24 | $65.0M | $99.0M | ||
| Q2 24 | $11.1M | $300.0M | ||
| Q1 24 | $-100.0K | $30.0M |
| Q4 25 | 8.3% | 6.4% | ||
| Q3 25 | 5.6% | 13.6% | ||
| Q2 25 | 9.0% | 11.4% | ||
| Q1 25 | 1.7% | 2.8% | ||
| Q4 24 | 25.4% | 21.0% | ||
| Q3 24 | 14.3% | 6.3% | ||
| Q2 24 | 2.8% | 18.7% | ||
| Q1 24 | -0.0% | 1.8% |
| Q4 25 | 3.4% | 3.0% | ||
| Q3 25 | 3.1% | 2.9% | ||
| Q2 25 | 2.0% | 2.4% | ||
| Q1 25 | 2.3% | 2.1% | ||
| Q4 24 | 2.1% | 3.5% | ||
| Q3 24 | 1.5% | 2.7% | ||
| Q2 24 | 2.6% | 2.0% | ||
| Q1 24 | 2.7% | 2.8% |
| Q4 25 | 2.21× | — | ||
| Q3 25 | 1.33× | 1.65× | ||
| Q2 25 | 30.06× | 1.52× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | 1.85× | 0.39× | ||
| Q2 24 | 0.70× | 1.70× | ||
| Q1 24 | 0.46× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
